Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Orion Pharma Ltd (ORIO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
73.10 -1.10    -1.48%
07/05 - Closed. Currency in BDT ( Disclaimer )
Type:  Equity
Market:  Bangladesh
ISIN:  BD0486OPL004 
S/N:  ORIONPHARM
  • Volume: 3,221,897
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 73.10 - 76.10
Orion Pharma 73.10 -1.10 -1.48%

DH:ORIO Financials

 
A brief overview of the DH:ORIO financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Orion Pharma Ltd over time.

Orion Pharma Limited reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported sales was BDT 2,035.3 million compared to BDT 2,297.65 million a year ago. Net income was BDT 99.22 million compared to BDT 123.87 million a year ago. Basic earnings per share from continuing operations was BDT 0.42 compared to BDT 0.53 a year ago.For the nine months, sales was BDT 7,780.5 million compared to BDT 10,210.82 million a year ago. Net income was BDT 386.13 million compared to BDT 571.62 million a year ago. Basic earnings per share from continuing operations was BDT 1.65 compared to BDT 2.44 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ORIO Income Statement

Gross margin TTM 18.85%
Operating margin TTM 5.97%
Net Profit margin TTM 3.96%
Return on Investment TTM 1.35%
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue 2035.3 2135.55 3609.65 3715.77
Gross Profit 515.23 622.77 588.17 441.44
Operating Income 171.06 171.76 225.03 118.19
Net Income 99.22 110.18 176.73 69.33

ORIO Balance Sheet

Quick Ratio MRQ 0.41
Current Ratio MRQ 1.86
LT Debt to Equity MRQ 92.08%
Total Debt to Equity MRQ 102.67%
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 52319.6 54419.37 54793.37 52939.68
Total Liabilities 29028.89 31901.77 32301.33 30605.63
Total Equity 23290.72 22517.61 22492.04 22334.06

ORIO Cash Flow Statement

Cash Flow/Share TTM 6.9
Revenue/Share TTM 49.13
Operating Cash Flow  1.11%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 96.41 -281.93 909.52 891.01
Cash From Investing Activities -7.88 -90.51 -833.57 -120.05
Cash From Financing Activities -16.88 314.52 -13.94 -1017.57
Net Change in Cash 71.64 -57.92 62.01 -246.61
* In Millions of BDT (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ORIO Comments

Write your thoughts about Orion Pharma Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Stock Amar
Stock Amar Sep 10, 2022 5:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
200 gone
nomanvilla villa
nomanvilla villa Oct 17, 2021 2:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good job
nomanvilla villa
nomanvilla villa Oct 17, 2021 2:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good job
shovo ahmed
shovo ahmed Sep 28, 2021 1:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good
Amrit Ahmed
Amrit Ahmed Sep 07, 2021 1:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
recently 100+
arman Khan
arman Khan Mar 30, 2021 4:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good stock
yusuf hasan
yusuf hasan Sep 05, 2020 12:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy orion target price 300 for 3year target
Show previous replies (6)
Azizur Rahman
Azizur Rahman Sep 05, 2020 12:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
index 10000
Azizur Rahman
Azizur Rahman Sep 05, 2020 12:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
inshaAllah tomorrow!!
Azizur Rahman
Azizur Rahman Sep 05, 2020 12:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I THINK IT WILL CROSS 80 SOON.
yusuf hasan
yusuf hasan Sep 05, 2020 12:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ASSALAMU ALIKUM MY BROTHER IM NOT M.F.GROUP IM FROM BOMBAY INDIA BUT MY STUDY ON ORION PHARMA IM SURE IT WILL X 300 INSHALLAH WATCH ORION PHARMA N GO FOR LONG
ataur rahman
ataur rahman Sep 05, 2020 12:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MD Sakinur Rahman
MD Sakinur Rahman Aug 20, 2020 10:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Orion pharma good Stock
MD Sakinur Rahman
MD Sakinur Rahman Aug 20, 2020 10:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good
Mohammad Saiful Islam
Mohammad Saiful Islam Mar 23, 2020 6:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Orion Pharma's management are now watching big dreams.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email